Instant Access to 2019 Annual Meeting Sessions

Access more than 100 sessions from the 2019 Annual Meeting.

The Virtual Meeting is an online product that includes access to more than 100 recorded sessions from SNMMI's 2019 Annual Meeting. 

Highlights include:

  • 24/7 online, anywhere access
  • Synchronized slides and audio of the most popular sessions
  • Includes the Plenary Sessions and Henry N. Wagner, Jr., MD Highlights Symposium
  • CME, ACPE and VOICE credit available for selected sessions

2019 Virtual Meeting Sessions

Featuring more than 100 sessions from SNMMI’s 2019 Annual Meeting—you get anytime access to the latest research and techniques in the profession. Plus, the Virtual Meeting’s easy-to-use platform allows you to instantly view sessions from the meeting where and when it’s most convenient, including your desktop computer, laptop, iPad, iPhone, or Android mobile devices.

Special Sessions – 5 Sessions

  • PL1: Opening Ceremony
  • PL2: Henry N. Wagner, Jr. MD Lectureship Plenary
  • PL3: SNMMI-TS Plenary Session
  • PL4: Hal Anger Lectureship and SNMMI Business Meeting
  • PL5: Henry N. Wagner, Jr. MD, Highlights Symposium

Scientific Sessions – 8 Sessions

  • SS08: Radiomics & Classification
  • SS16: Therapy Image Guided
  • SS24: System: Imaging & Performance Assessment
  • SS32: Sarcoma/Melanoma
  • SS40: Novel Multimodality & Nonradioactive Probes SS48:   Machine Learning in NM Imaging I: Image Processing & Clinical Tasks
  • SS56: GI--Pancreatic & Neuroendocrine SS70: Breast Cancer: Novel Tracer & Practice Advances

CE Sessions – 91 Sessions

  • CE01:  Initial Clinical Experiences with Digital PET/CT
  • CE02: Target Identification
  • CE04:  Nuts and Bolts: Using Lutetium-177 Dotatate
  • CE05:  Advancements in Brain Tumor Imaging
  • CE06: General Clinical Nuclear Medicine Council Award     Lectureship: The Evolving Paradigm of Radioiodine Therapeutics for Thyroid Cancer
  • CE07: Cardiovascular Molecular Imaging & Theranostics
  • CE08: Prostate Cancer Nuts and Bolts: Diagnosis and Therapy
  • CE09:  Nuts and Bolts - State-of-the-Art PET/CT:  Physics, Instrumentation, Performance and Clinical Application
  • CE10:  Community-Based Theranostics
  • CE11:  New Perspectives in the Diagnostic Approach of Neuroendocrine Tumors
  • CE12:  Cardiac PET Workshop
  • CE13:  Innovation in PET Instrumentation Enabled by Made-in-Japan Technologies
  • CE14: Binary V/Q Scintigraphy in North America - Highlight Country Session
  • CE15:  Differentiated Thyroid Cancer Theranostics Practicum
  • CE16: Management and Leadership in Nuclear Medicine and Molecular Imaging I
  • CE19: Barry Siegel Lecture: Correlative Imaging Using PET/CT and SPECT/CT; CIC Business with "Bites"
  • CE20:  Molecular Imaging for Immunotherapy
  • CE21: Non-Invasive Evaluation of CAD in 2019
  • CE22:  Joint ACR/SNMMI Session - Best Clinical Practice - PET/CT
  • CE23: Molecular Imaging in Drug Development
  • CE24:  Mental Health and Wellness in Nuclear Medicine
  • CE25: Management and Leadership in Nuclear Medicine and Molecular Imaging II
  • CE26:  Can We Use Quantitative PET in Clinical Practice?
  • CE27:  Molecular and Radiologic Imaging of Common and Uncommon Musculoskeletal Diseases Case-Based
  • CE28:  Present and Future of PRRT in the Treatment of Neuroendocrine Tumors
  • CE29:  New PET Radiopharmaceuticals - Read with the Experts
  • CE30:  Total Body PET and its Applications
  • CE31:  Tackling Diversified Clinical Management Questions
  • CE32:  Tele Nuclear Medicine:  The Success Stories - Highlight Country Session
  • CE33:  Implementing Inclusion and Diversity in Science, Clinic, and Training Sponsored by Women in Nuclear Medicine
  • CE34:  Radiation Dosimetry in Nuclear Oncology Practice - Striking a Balance in an Era of Theranostics (SNMMI Loevinger-Berman Award Session)
  • CE35: Cardiac Amyloidosis: Introduction and Applications
  • CE36:  PET/CT Assessment Response
  • CE37:  Cancer Immunotherapy: Current Status and Future Directions
  • CE38:  New Opportunities in Nuclear Medicine - Perspectives and Insights from Healthcare
  • CE39:  Current State of Development of New Theranostic Agents
  • CE40:  Kuhl-Lassen Award Lecture - Neurodegeneration Illuminated: Multimodal Imaging of Multifactorial Disease
  • CE41:  V/Q Lung Imaging: Pulmonary Embolism and Beyond
  • CE42: Nuts & Bolts of Myocardial Blood Flow: Clinical Applications
  • CE43:  Current Uses of MIBG and New Directions
  • CE44:  Physics, Instrumentation, Data Analysis Council Hoffman Award Lectureship
  • CE45:  History of Pediatric Nuclear Medicine, Radionuclide Production in Canada and the SNMMI
  • CE46:  Joint SNMMI-ASTRO Session:  Individualized Dosimetry for Theranostics
  • CE47:  Updates from the ACMUI
  • CE48:  Michael J. Welch Award Presentation and Lecture
  • CE49: Cardiovascular Boot Camp II
  • CE50: Saul Hertz Award Symposium: The Atomic Cocktail of Radioiodine Ushers in Precision Oncology
  • CE51: US Regulatory Pathways for Diagnostic and Therapy Radiopharmaceuticals
  • CE52:  Advanced Pediatric Imaging
  • CE53:  Diabetic Foot Osteomyelitis:  Diagnosing and Monitoring Treatment with Imaging
  • CE54: Dosimetry Methods and Dose/Effect Relationships
  • CE55: Valk Award Lecture - PET in Prostate Cancer: Frontierland and Tomorrowland
  • CE56: Case-Based Approach to Challenging Cases in Nuclear Medicine - Joint ARRS/SNMMI Session
  • CE57:  The Era of PRRT:  Personalization, Integration and Future Perspectives
  • CE58:  Practical Radiopharmaceutical Dosimetry
  • CE59:  Pediatric PET/MR
  • CE60: Neuroendocrine Tumor Diagnosis and Therapy
  • CE61: Technological Advances in PET/CT Imaging:  What you Really Need to Know - Highlight Country Session
  • CE62:  Career Paths in the Radiopharmaceutical Sciences
  • CE63:  Making the Transition from Training to the Nuclear Medicine Workforce
  • CE64:  Head and Neck CT Case Review (Cases 1-13)
  • CE65:  Radioisotope Production for Theranostics
  • CE66:  Pediatric Read with the Experts
  • CE67: Tom Miller Memorial Award Lecture - Academic Vigilance through Writing Letters to the Editor
  • CE68:  What Nuclear Medicine Physicians Need to Know about Epilepsy
  • CE69:  Theranostics 101:  Practical Clinical Aspects - Highlight Country Session
  • CE70:  Hermann Blumgart Award Lecture: Growing Research Opportunities in Cardiovascular Nuclear Medicine
  • CE71: Chest and Cardiac CT Case Review (Cases 14-25)
  • CE72:  Motion Correction: Basic Technology and Clinical Applications
  • CE73:  Personal Branding - Early Career Professionals Committee Session
  • CE74:  Nuts and Bolts: How Do I Get New Imaging Agents at My Site?
  • CE75:  Multi-Disciplinary Working the New Paradigm for Nuclear Medicine
  • CE76:  Nuts & Bolts of Ga-68 Radiochemistry
  • CE77:  Cardiac Image Quantification
  • CE78:  Musculoskeletal CT Case Review
  • CE79:  Joint AAPM/SNMMI Symposium - Bridging Nuclear Medicine and Radiation Therapy Towards Precision Oncology
  • CE80: A Debate - Linear No-Threshold: True or False?
  • CE81:  PET Melanoma in the Age of Immunotherapy
  • CE82:  Implementation of the New Neuroimaging Framework for the Diagnosis of Alzheimer's Disease
  • CE83: Imaging and Therapy for Thyroid Cancer: The Theranostics Paradigm
  • CE84: Post-Operative Bone SPECT/CT in Orthopedics: From Image to Clinical Impact
  • CE85: Abdomen and Pelvis CT Case Review
  • CE86: AI for Data Sciences
  • CE87: Topic and Techniques in Radionuclide Production: The Science that Happens Before Radiolabeling
  • CE88: Risk-based Assessment for the Management of Thyroid Cancer - Joint ATA and SNMMI Session
  • CE89: Brain Imaging Read with the Experts
  • CE90: D-Day 01/01/2020 - The Nuclear Medicine Report:  How to Get Paid with PAMA
  • CE91: Sequencing Therapies for Metastatic Neuroendocrine Tumors - Joint SNMMI/NANETS Session

Technologist Sessions – 18 Sessions

  • TS01: Quality in Nuclear Medicine
  • TS02:  General Nuclear Medicine
  • TS04: ARRT Updates
  • TS05: Leadership and Mentoring: Becoming a Positive Role Model
  • TS08: Radiopharmacy/Radiation Safety II
  • TS09: Cardiovascular Boot Camp I
  • TS12:  Lu-177 Dotatate Therapy: A Radiologist and Technologist Perspective
  • TS13: Coding Update 2019 and Beyond
  • TS17: Differentiated Thyroid Cancer Management and Therapy Update
  • TS18: Updates on USP 825 and Isotope Production
  • TS23: PET Jeopardy!  Do you Know Your Stuff?
  • TS30: Beyond Routine Brain Imaging
  • TS32: The Business of Molecular Imaging - Quality Improvement and Outcome Improvement Techniques
  • TS33: MRI
  • TS34:  PET/CT:  Politics and the Future
  • TS36: Cardiac PET in 2019
  • TS37: A New Era - Healthcare and You


2019 Virtual Meeting CE Information           

Overall Activity Objectives:

By viewing the SNMMI 2019 Virtual Meeting, participants will be able to:

  • Examine and evaluate future directions in nuclear medicine, molecular imaging and therapy from a research and clinical perspective.
  • Describe the latest indications and applications of hybrid imaging and its impact on patient management.
  • Review standard, new, and relevant advances in molecular imaging including applications in oncology, cardiology, and neurology.
  • Discuss new therapeutic and diagnostic agents that are impacting the practice of nuclear medicine and molecular imaging.
  • Examine important regulatory information, procedures, and guidelines for imaging.
  • Apply basic CT and MRI principles to the interpretation of images

CE Process:

To receive CME credit, learners must view the presentations, achieve a score of 80% on the post-course assessment and complete the evaluation for each session by the expiration date listed below. Learners will have no more than 3 attempts to successfully complete the post-test. Release date: August 2018. Expiration date: August 2020.

Target Audience:

The target audience includes nuclear medicine and molecular imaging physicians, nuclear pharmacists and technologists.

Financial Disclosure

In accordance with ACCME and ACPE Revised Standards for Commercial Support and SNMMI Conflict-of-Interest Policy, the following individuals have indicated no relevant relationships that could be perceived as a real or apparent conflict of interest:

  • Scientific Program Committee
  • Education Committee
  • Continuing Education Committee
  • SNMMI Staff Members

Disclosure information for specific sessions can be found in the front matter of each session. Disclosure of a relationship is not intended to suggest or to condone bias but is made to provide participants with information that might be of potential importance to their evaluation of the activity.


Accreditation Statements:

Continuing Education Credit details for physicians, pharmacists and technologists are pending and will be released on September 1, 2018. Please note that not every session will offer CE Credit.

How do I access the 2019 SNMMI Virtual Meeting?

Click here to access the Virtual Meeting. Use your 6-digit SNMMI user name and password to login. 

I forgot my password, what should I do?

If you forget your password, allows you to reset your password. In this case, a new password is generated and sent to you to an email address provided. Reset password here.

When can I begin claiming credits through the 2019 SNMMI Virtual Meeting?

Credit claiming for the 2019 SNMMI Virtual Meeting will be available beginning on September 1, 2019. You will be able to claim credit through August 2021.

How do the credits work if I attended the live meeting?

If you attended the live meeting, you may only claim credits in the Virtual Meeting for those sessions that you did not attend at the live meeting.

How many credits can I earn for watching the Virtual Meeting online?

Up to 50 sessions will offer CE credit (CME, ACPE and VOICE). The total number of credits will be available in September 2019. 

Which sessions will have CE Credit through the Virtual Meeting?

Please see the tab Available Sessions for the complete list.

How do I claim CE credit for a session?

Look for the CE button next to a session. After viewing the video, click on the Resources Tab, then click on the link to take you to the assessment.

Why can't I see anything about CME, ACPE and VOICE on my mobile device or USB?

You can claim credits using your computer or Apple or Android tablet, but not from the USB or mobile phone. Presentations can be viewed on the USB and mobile phone as well, but credit can only be claimed using a computer or supported tablet.

Where can I find CME, ACPE and VOICE information and faculty disclosures?

You can view CME, ACPE and VOICE information for an individual session, once you have viewed the video and clicked on the Resource Tab to link to begin taking the assessment for CE credit.   

Where can I get my CE certificate?

Your certificate will be accessible via the SNMMI Learning Center where you will complete your evaluations and be able to print your certificate.

How do I pass the assessment after viewing the session presentations?

You are required to pass the assessment with a score of at least 80% to earn credit. You have three attempts to pass the assessment.

How do I find a specific presentation?

You can search for presentations by session title, lecture title, or speaker name by using the search box on the top of the page.


2019 Pricing 

  SNMMI Member
/Annual Meeting Attendee Price
Non-Member Price
2019 Virtual Meeting Online Only $339  $429

Order the 2019 Virtual Meeting

Access Past SNMMI Virtual Meetings:

  SNMMI Member
/Annual Meeting Attendee Price
Non-Member Price

2018 Virtual Meeting "Specialty" Packages (per package)

Available packages:

  • Cardiovascular
  • General Clinical Specialties
  • Neursciences
  • Oncology and Therapy
  • Technologist





Order Today!

Now Available for Purchase!

Order the 2019 Virtual Meeting

View a Sample/Demo

Virtual Meeting Sample Session

Demo from the 2017 Virtual Poster Hall


Already Purchased?

Contact Us

Questions Regarding the 2019 Virtual Meeting?

Contact the SNMMI Education Department:

Phone: 703.708.9000